Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000630415 | SCV000751371 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002360503 | SCV002663010 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-07-25 | criteria provided, single submitter | clinical testing | The c.706-5T>C intronic variant results from a T to C substitution 5 nucleotides upstream from coding exon 7 in the PMS2 gene. This nucleotide position is conserved on limited sequence alignment. Using the BDGP and ESEfinder splice site prediction tools, this alteration is not predicted to have any significant effect on this splice acceptor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Color Diagnostics, |
RCV002360503 | SCV004359666 | likely benign | Hereditary cancer-predisposing syndrome | 2020-01-28 | criteria provided, single submitter | clinical testing |